These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19887821)

  • 1. Omental fat receptor interacting protein 140 mRNA expression in women with polycystic ovary syndrome.
    Seow KM; Tsai YL; Juan CC; Huang LW; Hwang JL; Ho LT
    Gynecol Obstet Invest; 2010; 69(1):51-6. PubMed ID: 19887821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipocyte resistin mRNA levels are down-regulated by laparoscopic ovarian electrocautery in both obese and lean women with polycystic ovary syndrome.
    Seow KM; Juan CC; Ho LT; Hsu YP; Lin YH; Huang LW; Hwang JL
    Hum Reprod; 2007 Apr; 22(4):1100-6. PubMed ID: 17208941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amelioration of insulin resistance in women with PCOS via reduced insulin receptor substrate-1 Ser312 phosphorylation following laparoscopic ovarian electrocautery.
    Seow KM; Juan CC; Hsu YP; Hwang JL; Huang LW; Ho LT
    Hum Reprod; 2007 Apr; 22(4):1003-10. PubMed ID: 17204522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body fat composition and distribution in women with polycystic ovary syndrome.
    Cosar E; Uçok K; Akgün L; Köken G; Sahin FK; Arioz DT; Baş O
    Gynecol Endocrinol; 2008 Aug; 24(8):428-32. PubMed ID: 18850379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose.
    Tan BK; Adya R; Farhatullah S; Lewandowski KC; O'Hare P; Lehnert H; Randeva HS
    Diabetes; 2008 Apr; 57(4):801-8. PubMed ID: 18174521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omental adipose tissue overexpression of fatty acid transporter CD36 and decreased expression of hormone-sensitive lipase in insulin-resistant women with polycystic ovary syndrome.
    Seow KM; Tsai YL; Hwang JL; Hsu WY; Ho LT; Juan CC
    Hum Reprod; 2009 Aug; 24(8):1982-8. PubMed ID: 19423542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal response of insulin to glucose loading and assessment of insulin resistance in non-obese patients with polycystic ovary syndrome.
    Takeuchi T; Tsutsumi O; Taketani Y
    Gynecol Endocrinol; 2008 Jul; 24(7):385-91. PubMed ID: 18645711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection and significance of phosphatidylinositol 3-kinase in adipose tissue of polycystic ovary syndrome patients with insulin resistance].
    Chu YL; Qiu HY; Sun YY; Li M; Li HF
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):455-8. PubMed ID: 17083810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance.
    Tan BK; Heutling D; Chen J; Farhatullah S; Adya R; Keay SD; Kennedy CR; Lehnert H; Randeva HS
    Diabetes; 2008 Jun; 57(6):1501-7. PubMed ID: 18375437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
    Ardawi MS; Rouzi AA
    Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
    Sepilian V; Nagamani M
    J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
    Koo YA; Shin SY; Yoon BK; Choi D
    Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
    Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of visfatin mRNA in peripheral blood mononuclear cells is not correlated with visfatin mRNA in omental adipose tissue in women with polycystic ovary syndrome.
    Seow KM; Hwang JL; Wang PH; Ho LT; Juan CC
    Hum Reprod; 2011 Oct; 26(10):2869-73. PubMed ID: 21840905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome.
    Baranowska B; Radzikowska M; Wasilewska-Dziubińska E; Kapliński A; Roguski K; Płonowski A
    Gynecol Endocrinol; 1999 Oct; 13(5):344-51. PubMed ID: 10599552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome.
    Kulshreshtha B; Ganie MA; Praveen EP; Gupta N; Lal Khurana M; Seith A; Dwivedi SN; Kumar G; Ammini AC
    Gynecol Endocrinol; 2008 Nov; 24(11):637-43. PubMed ID: 19031221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome.
    Fenkci SM; Fenkci V; Oztekin O; Rota S; Karagenc N
    Hum Reprod; 2008 Jul; 23(7):1602-6. PubMed ID: 18378560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation between single nucleotide polymorphism of insulin receptor gene with polycystic ovary syndrome].
    Chen ZJ; Shi YH; Zhao YR; Li Y; Tang R; Zhao LX; Chang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):582-5. PubMed ID: 15498182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity, body composition and metabolic disturbances in polycystic ovary syndrome.
    Svendsen PF; Nilas L; Nørgaard K; Jensen JE; Madsbad S
    Hum Reprod; 2008 Sep; 23(9):2113-21. PubMed ID: 18556679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome.
    Carmina E; Lobo RA
    Fertil Steril; 2004 Sep; 82(3):661-5. PubMed ID: 15374711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.